HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme. 1991

I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
INSERM U93, Saint Louis Hospital, Paris, France.

Erythema multiforme (EM) is an acute, episodic inflammatory disorder of the skin and mucous membranes of various etiology that could be related to immunologic hypersensitivity response. EM has been previously reported to be associated with serologically defined HLA-DRw53 and DQw3 antigens. In this report, we reevaluate the role of HLA class II alleles in EM manifestations. With use of the polymerase chain reaction, followed by sequence-specific oligonucleotide hybridization, 35 unrelated Caucasian EM patients and 80 randomly selected healthy subjects were studied, and the DRB3, DRB4, DQA1, and DQB1 alleles were analyzed. The comparison of frequencies of these alleles indicates that (i) susceptibility to EM disease is more associated with the HLA-DQ than the HLA-DR subregions and (ii) that the DQB1*0301 is the most frequent allele among EM patients. Sixty-six percent of the patients had the DQB1*0301 allele compared to 31% of the controls (RR = 4.1; p less than 0.001). An even stronger DQB1*0301 association was found in the patient group with herpes-associated EM (76%; RR = 6.5; p less than 0.001). Our data demonstrate a clear association between an HLA-DQB1 allele and susceptibility to EM.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004892 Erythema Multiforme A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic "bull's-eye" lesions usually occurring on the dorsal aspect of the hands and forearms.
D005260 Female Females
D006683 HLA-DQ Antigens A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-DC Antigens,HLA-MB Antigens,HLA-DC,HLA-DQ,HLA-DS,HLA-DS Antigens,HLA-LB,HLA-LB Antigens,HLA-MB,Antigens, HLA-DC,Antigens, HLA-DQ,Antigens, HLA-DS,Antigens, HLA-LB,Antigens, HLA-MB,HLA DC Antigens,HLA DQ Antigens,HLA DS Antigens,HLA LB Antigens,HLA MB Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
February 1997, The Journal of investigative dermatology,
I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
January 1994, Dermatology (Basel, Switzerland),
I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
January 2007, Human immunology,
I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
August 1996, Proceedings of the National Academy of Sciences of the United States of America,
I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
January 2023, HLA,
I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
September 1988, Tissue antigens,
I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
November 1994, International journal of cancer,
I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
March 2007, Tissue antigens,
I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
January 2008, Tissue antigens,
I Khalil, and V Lepage, and C Douay, and L Morin, and R al-Daccak, and D Wallach, and O Binet, and F Lemarchand, and L Degos, and J Hors
April 2002, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!